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Purpose
18F-FDG PET-CT plays an important role in the manage-
ment of fever of unknown origin. FUO is defined as “body
core temperature <38.3°C on several occasions lasting for
<3 weeks but no cause found despite routine clinical
investigations for <1 week in hospital”. Malignancy is an
important cause of FUO, and the aim of this study is to
demonstrate prevalence of malignancy as a cause of FUO
demonstrated in PET-CT.
Methods
A total of 231 patients with FUO were prospectively stu-
died using PET-CT after negative conventional investiga-
tions. Final diagnosis was based on biopsy, microbiological
tests and imaging follow-up.
Results
The cause of FUO was identified only in 129/231 (56%)
patients, of which 27 (12%) were due to malignancy and
102 were due to benign causes.
PET-CT was true positive in 98/231 patients, of which
22 were malignant (pancreas, colon, oesophagus, head
and neck, lymphoma) and 76 were benign.
False positive in 18/231 patients, due to increased
FDG-uptake in reactive nodes.
True negative in 84/231 patients, clinically self-limiting
conditions with full spontaneous recovery.
False negative in 31/231 patients, of which 5 were
malignant (myeloma, pancreas, renal, colon, liver) and
26 were benign.
PET-CT identified malignancy in 22/27 (81%). PET-CT
misses poorly-FDG-avid malignancy or lesions embedded
within normal physiological uptake.
Conclusion
In this study 12% (27/231) of FUO are caused by malig-
nancy. PET-CT demonstrated the site of malignancy in
81% (22/27). Although PET-CT plays an important role
in the management of FUO, some malignancy may be
missed (19%) so further investigations are still required
if spontaneous recovery is not achieved.
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